e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Published

Digital Health Products and Their Regulatory Challenges

Published in March 2026 Issue 03 (Vol. 14, Issue 3, 2026)

Digital Health Products and Their Regulatory Challenges - Issue cover

Abstract

Mobile health applications, wearable devices, telehealth platforms, artificial intelligence (AI) applications, and electronic health records have changed healthcare delivery through improving access, efficiency, and participation of patients. Regulatory affairs will have an essential part in assuring the safety, effectiveness, quality, and data security of digital health innovations as they expand and grow fast. By influencing how we classify products, evaluate risk, clinically validate, secure cybersecurity, improve interoperability, and evaluate post-market regulatory pathways, we seek to find a balance between innovation and patient safety. Keywords: Artificial Intelligence (AI), Mobile Health, Quality Assurance

Authors (2)

Shubham.S.Wadate

YSPM’s YTC Faculty of Pharmacy...

View all publications →

Aneri.V.Adsul

YSPM’s YTC Faculty of Pharmacy...

View all publications →

Download Article

DOCX

Best for printing and citation

File size: 0.1 MB
Format: DOCX

Download Article

DOCX

Best for printing and citation

File size: 0.1 MB
Format: DOCX

Article Information

AJPHR3140002

AJPHR-91-000006

19-28

2026-03-20

Article Impact

Views:5,869
Downloads:1,873

How to Cite

APA
MLA
Chicago
Harvard
Vancouver
IEEE
ACM
ACS
ABNT
Turabian
RIS (EndNote/Zotero/Mendeley)
BibTeX

Shubham.S.Wadate & Aneri.V.Adsul (2026). Digital Health Products and Their Regulatory Challenges. American Journal of Pharmacy and Health Research, 14(3), 19-28. https://ajphr.com/articles/AJPHR3140002

Article Actions